Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02386800
Title CINC424A2X01B Rollover Protocol
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

myelofibrosis

Therapies

Ruxolitinib

Panobinostat + Ruxolitinib

Age Groups: child | adult | senior
Covered Countries ITA | FRA | ESP | DEU | BEL


No variant requirements are available.